Clinical Trials

Small Cell Lung Carcinoma

NCT07192926 2026-02-20

SARCO-CTI

131 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

NCT06634199 2026-01-28

SIENNA

Recruiting

50 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06252753 2025-12-26

LIVER-R

Recruiting

4,490 enrolled

Gastrointestinal

Hepatobiliary Cancers

NCT06826677 2025-06-24

ARAL

71 enrolled

Small Cell Lung Carcinoma

NCT04667312 2023-10-02

CODAK

115 enrolled

Non-Small Cell Lung Cancer NSCLC

NCT04364776 2023-09-28

Radiomic Signature as Predictive Marker of Response to Chemoradiation and Durvalumab in Stage III NSCLC.

100 enrolled

Lung Neoplasms

NCT05933044 2023-09-05

RELEVANCE

662 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02154490 2023-06-01

Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

1,864 enrolled 12 charts

Recurrent Squamous Cell Lung Carcinoma

NCT04107168 2023-02-16

Microbiome Immunotherapy Toxicity and Response Evaluation

DermatologicGenitourinaryThoracic

1,800 enrolled

Kidney Neoplasms, Lung Neoplasms, Melanoma

NCT04359199 2023-02-10

QUASAR

42 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT04285866 2022-06-07

S-REAL

245 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04672759 2020-12-17

A Real-world Study of Durvalumab for Lung Cancer in China

100 enrolled